Impact of Health-related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice in Low- and Intermediate-Risk Prostate Cancer

Ferlay Fletcher, 2020, Contemporary national trends in prostate cancer risk profile at diagnosis, Prostate Cancer Prostatic Dis, 23, 81, 10.1038/s41391-019-0157-y Sanda, 2018, Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options, J Urol, 199, 683, 10.1016/j.juro.2017.11.095 Hoffman, 2014, Physician variation in management of low-risk prostate cancer: a population-based cohort study, JAMA Intern Med, 174, 1450, 10.1001/jamainternmed.2014.3021 Meeks, 2011, A tune in “a minor” can “b major”: a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults, J Affect Disord, 129, 126, 10.1016/j.jad.2010.09.015 Cuypers, 2018, The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset, Support Care Cancer, 26, 1297, 10.1007/s00520-017-3953-8 Erim, 2019, Prevalence and predictors of probable depression in prostate cancer survivors, Cancer, 125, 3418, 10.1002/cncr.32338 Ediebah, 2018, Quality of life as a prognostic indicator of survival: a pooled analysis of individual patient data from Canadian Cancer Trials Group clinical trials, Cancer, 124, 3409, 10.1002/cncr.31556 Braun, 2012, Predicting survival in prostate cancer: the role of quality of life assessment, Support Care Cancer, 20, 1267, 10.1007/s00520-011-1213-x Haigh, 2018, Depression among older adults: a 20-year update on five common myths and misconceptions, Am J Geriatr Psychiatry, 26, 107, 10.1016/j.jagp.2017.06.011 Ambs, 2008, Overview of the SEER--Medicare Health Outcomes Survey linked dataset, Health Care Financ Rev, 29, 5 National Cancer Institute. Overview of the SEER program. https://seer.cancer.gov/about/overview.html. Rost, 1993, Development of screeners for depressive disorders and substance disorder history, Med Care, 31, 189, 10.1097/00005650-199303000-00001 Buscariollo, 2019, Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women, Breast Cancer Res Treat, 173, 709, 10.1007/s10549-018-5006-5 van Dams, 2019, Impact of health-related quality of life and prediagnosis risk of major depressive disorder on treatment choice for stage I lung cancer, JCO Clin Cancer Informatics, 3, 1, 10.1200/CCI.19.00072 Reeve, 2012, Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study, Cancer, 118, 5679, 10.1002/cncr.27578 NCCN. Clinical practice guidelines in oncology: prostate cancer; version 4.2019. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Hamdy, 2016, 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer, N Engl J Med, 375, 1415, 10.1056/NEJMoa1606220 Mahal, 2019, Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010–2015, JAMA, 321, 704, 10.1001/jama.2018.19941 Butler, 2019, Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer, Cancer, 125, 3164, 10.1002/cncr.32202 Dahabreh, 2012, Active surveillance in men with localized prostate cancer: a systematic review, Ann Intern Med, 156, 582, 10.7326/0003-4819-156-8-201204170-00009 Kinsella, 2018, Factors influencing men’s choice of and adherence to active surveillance for low-risk prostate cancer: a mixed-method systematic review, Eur Urol, 74, 261, 10.1016/j.eururo.2018.02.026 Shaverdian, 2017, Exploring value from the patient’s perspective between modern radiation therapy modalities for localized prostate cancer, Int J Radiat Oncol, 97, 516, 10.1016/j.ijrobp.2016.11.007 Lamers, 2017, How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer, Urol Oncol Semin Orig Investig, 35, 37 Jayadevappa, 2019, Patient-centered approach to develop the Patient’s Preferences for Prostate Cancer Care (PreProCare) tool, MDM Policy Pract, 4 Showalter, 2015, Factors that influence patient preferences for prostate cancer management options: a systematic review, Patient Prefer Adherence, 9, 899, 10.2147/PPA.S83333 Doll, 2017, Pre-diagnosis health-related quality of life, surgery, and survival in women with advanced epithelial ovarian cancer: a SEER-MHOS study, Gynecol Oncol, 144, 348, 10.1016/j.ygyno.2016.12.005 Prasad, 2014, Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer, J Clin Oncol, 32, 2471, 10.1200/JCO.2013.51.1048